Additionally, TREM2 is required for the protective role in attenuating the expression of pro-inflammatory mediators, including iNOS, TNFα, IL-1β, and IL-6, as well as mediating phagocytosis of TDP-43 aggregates in the context of ALS. Here, TARDBP is linked to amyotrophic lateral sclerosis.